- Home
- TFX
as 11-20-2024 4:00pm EST
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
| Founded: | 1943 | Country: | United States |
| Employees: | N/A | City: | WAYNE |
| Market Cap: | 9.0B | IPO Year: | N/A |
| Target Price: | $259.00 | AVG Volume (30 days): | 531.9K |
| Analyst Decision: | Buy | Number of Analysts: | 9 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 5.03 | EPS Growth: | -41.10 |
| 52 Week Low/High: | $185.84 - $257.85 | Next Earning Date: | 10-31-2024 |
| Revenue: | $3,025,824,000 | Revenue Growth: | 2.27% |
| Revenue Growth (this year): | 4.52% | Revenue Growth (next year): | 4.92% |
Latest Teleflex Incorporated News
TFX Breaking Stock News: Dive into TFX Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Here's Why Teleflex (TFX) is a Strong Value Stock
GlobeNewswire
2 days ago
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
Argus Research
8 days ago
TFX: Lowering target price to $205.00
Morningstar Research
12 days ago
Analyst Report: Teleflex Incorporated
GlobeNewswire
14 days ago
Teleflex to Present at the Jefferies London Healthcare Conference
Argus Research
15 days ago
TFX: Lowering target price to $214.00
Zacks
16 days ago
Here's Why Teleflex (TFX) is a Strong Growth Stock
Simply Wall St.
19 days ago
Teleflex Incorporated (NYSE:TFX) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates
Compare TFX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TFX Teleflex Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.